JAMP-OLMESARTAN HCTZ
JAMP-OLMESARTAN HCTZ
Dormant
DIN Number
02462052
Drug Class
Human
Market Date
May 10, 2017
Company
HC
Jamp Pharma Corporation
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02462052
AIG Number0252502003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C09DA08 OLMESARTAN MEDOXOMIL AND DIURETICS
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification24:32.08
Health Canada Classification
ACTIVE INGREDIENTS (2)
HYDROCHLOROTHIAZIDEActive
Strength: 25 MG
Monograph: HYDROCHLOROTHIAZIDE
OLMESARTAN MEDOXOMILActive
Strength: 40 MG
Monograph: OLMESARTAN MEDOXOMIL